Primary aldosteronism: Changes in cystatin C-based kidney filtration, proteinuria, and renal duplex indices with treatment

Journal of Hypertension

Volumn 29, Issue 9, 2011, Pages 1778-1786

  Wu, Vin Cent ^a   Kuo, Chin Chi ^b   Wang, Shuo Meng ^b   Liu, Kao Lang ^a   Huang, Kuo How ^b   Lin, Yen Hung ^a   Chu, Tzong Shinn ^a   Chang, Hung Wei ^a   Lin, Chien Yu ^c   Tsai, Chia Ti ^a   Lin, Lian Yu ^a   Chueh, Shih Chieh ^b,d   Kao, Tze Wah ^a   Chen, Yung Ming ^a   Chiang, Wen Chih ^a   Tsai, Tun Jun ^a   Ho, Yi Luwn ^a   Lin, Shuei Liong ^a   Wang, Wei Jei ^e   Wu, Kwan Dun ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b Department of Yun Lin Branch ^*  (Taiwan)

^c EN CHU KONG HOSPITAL   (Taiwan)

^d LERNER RESEARCH INSTITUTE   (United States)

^e TAO YUAN GENERAL HOSPITAL   (Taiwan)

Author keywords

albuminuria; cystatin C; Doppler indices; hyperfiltration; primary aldosteronism

Indexed keywords

ALDOSTERONE; CYSTATIN C; SPIRONOLACTONE;

ADENOMA; ADRENALECTOMY; ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; ESSENTIAL HYPERTENSION; FEMALE; GLOMERULUS FILTRATION; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; LASER DOPPLER FLOWMETRY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN DEPLETION; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 80051936847     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3283495cbb     Document Type: Article

References (45)

1. Olivieri O, Ciacciarelli A, Signorelli D, Pizzolo F, Guarini P, Pavan C, et al. Aldosterone to renin ratio in a primary care setting: the Bussolengo study. J Clin Endocrinol Metab 2004; 89:4221-4226. (Pubitemid 39244414)
2. Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, et al. A prospective study of the prevalence of primary aldosteronism in 1125 hypertensive patients. J Am Coll Cardiol 2006; 48:2293-2300. (Pubitemid 44873058)
3. Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 2005; 45:1243-1248. (Pubitemid 40523144)
4. Wu VC, Chueh SC, Chang HW, Lin LY, Liu KL, Lin YH, et al. Association of kidney function with residual hypertension after treatment of aldosteroneproducing adenoma. Am J Kidney Dis 2009; 54:665-673.
5. Reincke M, Rump LC, Quinkler M, Hahner S, Diederich S, Lorenz R, et al. Risk factors associated with a low glomerular filtration rate in primary aldosteronism. J Clin Endocrinol Metab 2008; 94:869-875.
6. Horita Y, Inenaga T, Nakahama H, Ishibashi-Ueda H, Kawano Y, Nakamura S, et al. Cause of residual hypertension after adrenalectomy in patients with primary aldosteronism. Am J Kidney Dis 2001; 37:884-889. (Pubitemid 32471846)
7. Ribstein J, Du Cailar G, Fesler P, Mimran A. Relative glomerular hyperfiltration in primary aldosteronism. J Am Soc Nephrol 2005; 16:1320-1325. (Pubitemid 41716516)
8. Rossi GP, Bernini G, Desideri G, Fabris B, Ferri C, Giacchetti G, et al. Renal damage in primary aldosteronism: results of the PAPY study. Hypertension 2006; 48:232-238. (Pubitemid 44309817)
9. Sechi LA, Novello M, Lapenna R, Baroselli S, Nadalini E, Colussi GL, et al. Long-term renal outcomes in patients with primary aldosteronism. JAMA 2006; 295:2638-2645. (Pubitemid 43882339)
10. Sechi LA, Di Fabio A, Bazzocchi M, Uzzau A, Catena C. Intrarenal hemodynamics in primary aldosteronism before and after treatment. J Clin Endocrinol Metab 2009; 94:1191-1197.
11. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002:S1-S266.
12. Huang SH, Sharma AP, Yasin A, Lindsay RM, Clark WF, Filler G. Hyperfiltration affects accuracy of creatinine eGFR measurement. Clin J Am Soc Nephrol 2011; 6:274-280.
13. Grubb A, Nyman U, Bjork J, Lindstrom V, Rippe B, Sterner G, et al. Simple cystatin C-based prediction equations for glomerular filtration rate compared with the modification of diet in renal disease prediction equation for adults and the Schwartz and the Counahan-Barratt prediction equations for children. Clin Chem 2005; 51:1420-1431. (Pubitemid 41060874)
14. Taglieri N, Koenig W, Kaski JC. Cystatin C and cardiovascular risk. Clin Chem 2009; 55:1932-1943.
15. Premaratne E, MacIsaac RJ, Finch S, Panagiotopoulos S, Ekinci E, Jerums G. Serial measurements of cystatin C are more accurate than creatininebased methods in detecting declining renal function in type 1 diabetes. Diabetes Care 2008; 31:971-973.
16. Perkins BA, Nelson RG, Ostrander BE, Blouch KL, Krolewski AS, Myers BD, et al. Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study. J Am Soc Nephrol 2005; 16:1404-1412. (Pubitemid 41716524)
17. Wu VC, Chang HW, Liu KL, Lin YH, Chueh SC, Lin WC, et al. Primary aldosteronism: diagnostic accuracy of the losartan and captopril tests. Am J Hypertens 2009; 22:821-827.
18. Wu VC, Kuo CC, Chang HW, Tsai CT, Lin CY, Lin LY, et al. Diagnosis of primary aldosteronism: comparison of postcaptopril active renin concentration and plasma renin activity. Clin Chim Acta 2010; 411:657-663.
19. Wu VC, Chueh SC, Chang HW, Lin WC, Liu KL, Li HY, et al. Bilateral aldosterone-producing adenomas: differentiation from bilateral adrenal hyperplasia. QJM 2008; 101:13-22.
20. Kuo CC, Wu VC, Huang KH, Wang SM. Verification and evaluation of aldosteronism demographics in the Taiwan Primary Aldosteronism Investigation Group (TAIPAI Group). J Renin Angiotensin Aldosterone Syst 2011. [Epub ahead of print].
21. Wu KD, Liao TS, Chen YM, Lai MK, Chen SJ, Su CT, et al. Preoperative diagnosis and localization of aldosterone-producing adenoma by adrenal venous sampling after administration of metoclopramide. J Formos Med Assoc 2001; 100:598-603.
22. Rossi GP, Belfiore A, Bernini G, Desideri G, Fabris B, Ferri C, et al. Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma. Hypertension 2007; 50:424-431. (Pubitemid 47205795)
23. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16:31-41.
24. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130:461-470. (Pubitemid 29135798)
25. Thomas L, Huber AR. Renal function: estimation of glomerular filtration rate. Clin Chem Lab Med 2006; 44:1295-1302. (Pubitemid 44706706)
26. Selvin E, Kottgen A, Coresh J. Kidney function estimated from serum creatinine and cystatin C and peripheral arterial disease in NHANES. Eur Heart J 2009; 30:1918-1925.
27. Stevens LA, Coresh J, Schmid CH, Feldman HI, Froissart M, Kusek J, et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3418 individuals with CKD. Am J Kidney Dis 2008; 51:395-406. (Pubitemid 351273480)
28. Weinberger MH, Fineberg NS. The diagnosis of primary aldosteronism and separation of two major subtypes. Arch Intern Med 1993; 153:2125-2129. (Pubitemid 23286466)
29. Woo MJ, Reiter JP, Karr AF. Estimation of propensity scores using generalized additive models. Stat Med 2008; 27:3805-3816.
30. MaderoM, Wassel CL, Peralta CA, Najjar SS, Sutton-Tyrrell K, Fried L, et al. Cystatin C associates with arterial stiffness in older adults. J Am Soc Nephrol 2009; 20:1086-1093.
31. Kuo CC, Wu VC, Huang CC, Tsai CW, Lin WC, Lin YH, et al. Renal hyperfiltration in primary aldosteronism: a meta analysis. J Clin Hypertens (Greenwich) 2009; 11:400.
32. Hollenberg NK. Aldosterone in the development and progression of renal injury. Kidney Int 2004; 66:1-9. (Pubitemid 38870076)
33. Lam EY, Funder JW, Nikolic-Paterson DJ, Fuller PJ, Young MJ. Mineralocorticoid receptor blockade but not steroid withdrawal reverses renal fibrosis in deoxycorticosterone/salt rats. Endocrinology 2006; 147:3623-3629. (Pubitemid 43901155)
34. Liang W, Chen C, Shi J, Ren Z, Hu F, van Goor H, et al. Disparate effects of eplerenone, amlodipine and telmisartan on podocyte injury in aldosteroneinfused rats. Nephrol Dial Transplant 2011; 26:789-799.
35. Weir MR. Microalbuminuria and cardiovascular disease. Clin J Am Soc Nephrol 2007; 2:581-590.
36. Zhu C, Huang S, Yuan Y, Ding G, Chen R, Liu B, et al. Mitochondrial dysfunction mediates aldosterone-induced podocyte damage: a therapeutic target of PPAR gamma. Am J Pathol 2011; 178:2020-2031.
37. Arima S, Kohagura K, Xu HL, Sugawara A, Abe T, Satoh F, et al. Nongenomic vascular action of aldosterone in the glomerular microcirculation. J Am Soc Nephrol 2003; 14:2255-2263. (Pubitemid 37052371)
38. Whaley-Connell A, Habibi J, Wei Y, Gutweiler A, Jellison J, Wiedmeyer CE, et al. Mineralocorticoid receptor antagonism attenuates glomerular filtration barrier remodeling in the transgenic Ren2 rat. Am J Physiol Renal Physiol 2009; 296:F1013-1022.
39. Heindl S, Holzschneider J, Hinz A, Sayk F, Fehm HL, Dodt C. Acute effects of aldosterone on the autonomic nervous system and the baroreflex function in healthy humans. J Neuroendocrinol 2006; 18:115-121.
40. Sigirci A, Hallac T, Akyncy A, Temel I, Gulcan H, Aslan M, et al. Renal interlobar artery parameters with duplex Doppler sonography and correlations with age, plasma renin, and aldosterone levels in healthy children. AJR Am J Roentgenol 2006; 186:828-832. (Pubitemid 46100271)
41. Koda M, Murawaki Y, Kawasaki H. Renovascular resistance assessed by color Doppler ultrasonography in patients with chronic liver diseases. J Gastroenterol Hepatol 2000; 15:1424-1429. (Pubitemid 32052917)
42. Radermacher J, Ellis S, Haller H. Renal resistance index and progression of renal disease. Hypertension 2002; 39:699-703. (Pubitemid 34165209)
43. Segura J, Campo C, Gil P, Roldan C, Vigil L, Rodicio JL, et al. Development of chronic kidney disease and cardiovascular prognosis in essential hypertensive patients. J Am Soc Nephrol 2004; 15:1616-1622. (Pubitemid 38679687)
44. Strauch B, Petrak O, Zelinka T, Wichterle D, Holaj R, Kasalicky M, et al. Adrenalectomy improves arterial stiffness in primary aldosteronism. Am J Hypertens 2008; 21:1086-1092.
45. Catena C, Colussi G, Lapenna R, Nadalini E, Chiuch A, Gianfagna P, et al. Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism. Hypertension 2007; 50:911-918. (Pubitemid 350287534)